Literature DB >> 20507993

The NC2 domain of collagen IX provides chain selection and heterotrimerization.

Sergei P Boudko1, Keith D Zientek, Jesse Vance, Jessica L Hacker, Jürgen Engel, Hans Peter Bächinger.   

Abstract

The mechanism of chain selection and trimerization of fibril-associated collagens with interrupted triple helices (FACITs) differs from that of fibrillar collagens that have special C-propeptides. We recently showed that the second carboxyl-terminal non-collagenous domain (NC2) of homotrimeric collagen XIX forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. We then hypothesized a general trimerizing role for the NC2 domain in other FACITs. Here we analyzed the NC2 domain of human heterotrimeric collagen IX, the only member of FACITs with all three chains encoded by distinct genes. Upon oxidative folding of equimolar amounts of the alpha1, alpha2, and alpha3 chains of NC2, a stable heterotrimer with a disulfide bridge between alpha1 and alpha3 chains is formed. Our experiments show that this heterotrimerization domain can stabilize a short triple helix attached at the carboxyl-terminal end and allows for the proper oxidation of the cystine knot of type III collagen after the short triple helix.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507993      PMCID: PMC2911272          DOI: 10.1074/jbc.M110.128405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Collagenous sequence governs the trimeric assembly of collagen XII.

Authors:  M Mazzorana; S Cogne; D Goldschmidt; E Aubert-Foucher
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

2.  Structure formation in the C terminus of type III collagen guides disulfide cross-linking.

Authors:  Sergei P Boudko; Jürgen Engel
Journal:  J Mol Biol       Date:  2004-01-30       Impact factor: 5.469

Review 3.  Genetic and orthopedic aspects of collagen disorders.

Authors:  Erin M Carter; Cathleen L Raggio
Journal:  Curr Opin Pediatr       Date:  2009-02       Impact factor: 2.856

4.  Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family.

Authors:  P Holden; R S Meadows; K L Chapman; M E Grant; K E Kadler; M D Briggs
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

5.  Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX.

Authors:  J Thur; K Rosenberg; D P Nitsche; T Pihlajamaa; L Ala-Kokko; D Heinegård; M Paulsson; P Maurer
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

6.  Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease.

Authors:  R Fässler; P N Schnegelsberg; J Dausman; T Shinya; Y Muragaki; M T McCarthy; B R Olsen; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Analysis of the role of the COL1 domain and its adjacent cysteine-containing sequence in the chain assembly of type IX collagen.

Authors:  L Labourdette; M van der Rest
Journal:  FEBS Lett       Date:  1993-04-12       Impact factor: 4.124

8.  Alpha-helical coiled-coil oligomerization domains are almost ubiquitous in the collagen superfamily.

Authors:  Audrey McAlinden; Thomasin A Smith; Linda J Sandell; Damien Ficheux; David A D Parry; David J S Hulmes
Journal:  J Biol Chem       Date:  2003-08-14       Impact factor: 5.157

9.  Mechanisms of collagen trimer formation. Construction and expression of a recombinant minigene in HeLa cells reveals a direct effect of prolyl hydroxylation on chain assembly of type XII collagen.

Authors:  M Mazzorana; H Gruffat; A Sergeant; M van der Rest
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

Review 10.  Collagens, modifying enzymes and their mutations in humans, flies and worms.

Authors:  Johanna Myllyharju; Kari I Kivirikko
Journal:  Trends Genet       Date:  2004-01       Impact factor: 11.639

View more
  8 in total

Review 1.  The collagen family.

Authors:  Sylvie Ricard-Blum
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

2.  The NC2 domain of type IX collagen determines the chain register of the triple helix.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

3.  Crystal structure of the human collagen XV trimerization domain: a potent trimerizing unit common to multiplexin collagens.

Authors:  Jacqueline A Wirz; Sergei P Boudko; Thomas F Lerch; Michael S Chapman; Hans Peter Bächinger
Journal:  Matrix Biol       Date:  2010-10-13       Impact factor: 11.583

4.  Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding.

Authors:  Kazunori Mizuno; Sergei Boudko; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

5.  Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.

Authors:  Jean-Baptiste Oudart; Sylvie Brassart-Pasco; Alexia Vautrin; Christèle Sellier; Carine Machado; Aurelie Dupont-Deshorgue; Bertrand Brassart; S Baud; Manuel Dauchez; Jean-Claude Monboisse; Dominique Harakat; François-Xavier Maquart; Laurent Ramont
Journal:  Oncotarget       Date:  2015-02-28

6.  Structural insight for chain selection and stagger control in collagen.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

Review 7.  Collagen Mimetic Peptides.

Authors:  Yujia Xu; Michele Kirchner
Journal:  Bioengineering (Basel)       Date:  2021-01-05

Review 8.  Type XIX collagen: a promising biomarker from the basement membranes.

Authors:  Ana C Calvo; Laura Moreno; Leticia Moreno; Janne M Toivonen; Raquel Manzano; Nora Molina; Miriam de la Torre; Tresa López; Francisco J Miana-Mena; María J Muñoz; Pilar Zaragoza; Pilar Larrodé; Alberto García-Redondo; Rosario Osta
Journal:  Neural Regen Res       Date:  2020-06       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.